CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities:
Net loss	$ (186,638)	$ (151,293)	$ (143,032)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	56,139	41,168	26,756
Stock-based compensation	81,244	40,556	36,450
Amortization of debt discount and debt issuance costs	3,634	2,038	1,868
Amortization of right-of-use assets	3,543	2,760	3,418
Write-down for excess and obsolete inventories	13,608	9,792	11,147
Loss on disposal of assets	3,708	2,594	1,976
Loss on debt extinguishment, net			7,434
Impairment of investment			3,000
Other	455	1,187	2,721
Changes in operating assets and liabilities:
Accounts receivable	(12,795)	(18,832)	(10,141)
Inventories	(45,562)	(20,704)	(27,746)
Prepaid expenses and other current assets	(11,098)	552	1,258
Other assets	(541)	(109)	11
Accounts payable	6,989	9,796	757
Accrued expenses and other current liabilities	17,000	13,508	8,023
Lease liability	(3,602)	(2,678)	150
Contract liabilities	1,793	(2,280)	(1,040)
Other long-term liabilities	(6,362)	(3,189)	3,673
Net cash used in operating activities	(78,485)	(75,134)	(73,317)
Investing activities:
Purchases of property and equipment	(80,508)	(49,453)	(68,544)
Purchase of intangible assets	(6,467)	(8,827)
Acquisition of business, net of cash acquired	(55,000)		(62,133)
Purchase of OCEANE			(21,097)
Cash paid for investments			(3,000)
Settlement of forward contract			(2,988)
Net cash used in investing activities	(141,975)	(58,280)	(157,762)
Financing activities:
Proceeds from Revolving Credit Facility and line of credit	134,000	62,500
Payment of debt issuance costs	(3,321)	(1,315)	(10,028)
Proceeds from common stock offerings, net of offering costs	213,181		131,828
Proceeds from issuance of convertible notes			316,250
Net cash paid for common stock exercises	(1,064)	(3,041)	(5,963)
Purchase of capped calls			(39,866)
Repurchase of common stock			(25,000)
Proceeds from term debt, net of debt discount	148,473
Repayment of Revolving Credit Facility and line of credit	(119,500)	(27,500)
Repayment of OCEANEs	(13,315)
Repayment of Squadron Medical Term Loan			(45,000)
Repayment of Inventory Financing Agreement			(8,088)
Other	(1,535)	584	(2,167)
Net cash provided by financing activities	356,919	31,228	311,966
Effect of exchange rate changes on cash	(185)	(366)	(1,404)
Net change in cash and cash equivalents	136,274	(102,552)	79,483
Cash and cash equivalents at beginning of year	84,696	187,248	107,765
Cash and cash equivalents at end of year	220,970	84,696	187,248
Supplemental disclosure of cash flow information:
Cash paid for interest	17,269	3,860	5,027
Cash paid for income taxes	333	272	223
Supplemental disclosure of noncash investing and financing activities:
PPP Loan Forgiveness			4,271
Debt issuance costs		2,760
Financed insurance	1,328	1,959
Financed property and equipment		600
Financed inventory			4,015
Purchases of property and equipment in accounts payable and accrued expenses	10,406	2,128	2,577
Purchase of intangible assets	99	750
Recognition of lease liability	$ 424	1,694	$ 23,403
Modification of lease liability for lease amendment		$ 4,288